From: Association of plasma endothelial lipase levels on cognitive impairment
Total | control | MCI | AD | P-value | |
---|---|---|---|---|---|
N | 109 | 51 | 38 | 20 | |
Age | 75.3 ± 5.7 | 73.8 ± 4.9 | 75.3 ± 5.0 | 79.1 ± 7.2 | 0.002 |
Sex, male/female N (female %) | 37/72 (66%) | 10/41 (80%) | 19/19 (50%) | 8/12 (60%) | 0.009* |
Education, years | 9.8 ± 4.7 | 9.4 ± 5.2 | 10.6 ± 3.9 | 9.2 ± 4.9 | 0.413 |
BMI | 24.0 ± 2.7 | 24.2 ± 2.6 | 23.8 ± 2.7 | 24.0 ± 2.9 | 0.829 |
Total Protein (g/dL) | 7.0 ± 0.5 | 7.1 ± 0.5 | 7.0 ± 0.4 | 6.8 ± 0.5 | 0.046 |
Albumin (g/dL) | 4.3 ± 0.3 | 4.4 ± 0.3 | 4.4 ± 0.3 | 4.2 ± 0.3 | 0.010 |
Total Cholesterol (mg/dL) | 177.0 ± 32.0 | 174.1 ± 30.2 | 175.8 ± 31.4 | 186.8 ± 37.3 | 0.312 |
HDL-C (mg/dL) | 54.0 ± 16.5 | 56.9 ± 16.7 | 53.2 ± 16.4 | 50.1 ± 16.4 | 0.365 |
LDL-C (mg/dL) | 108.9 ± 30.0 | 104.9 ± 30.2 | 109.3 ± 28.6 | 118.2 ± 31.3 | 0.246 |
Triglyceride (mg/dL) | 149.3 ± 84.6 | 138.5 ± 62.4 | 152.0 ± 95.8 | 171.4 ± 108.2 | 0.330 |
ApoE4 carrier, N (%) | 36 (33%) | 11 (22%) | 14 (37%) | 11 (55%) | 0.022* |
Amyloid PET positive N (%) | 40 (37%) | 9 (18%) | 18 (47%) | 13 (65%) | < 0.001* |
CDR | 0.6 ± 0.5 | 0.4 ± 0.2 | 0.5 ± 0.1 | 1.5 ± 0.8 | < 0.001* |
CDR-SOB | 2.4 ± 3.7 | 0.7 ± 0.4 | 1.5 ± 1.1 | 8.8 ± 4.7 | < 0.001 |
MMSE | 25.0 ± 5.3 | 27.6 ± 2.1 | 25.9 ± 2.7 | 16.6 ± 6.4 | < 0.001 |
EL (ng/ml) | 21.4 ± 10.1 | 21.0 ± 8.8 | 21.9 ± 9.7 | 21.7 ± 14.2 | 0.899 |